vs
安捷伦科技（A）与908 Devices Inc.（MASS）财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是908 Devices Inc.的103.5倍（$1.8B vs $17.4M）。908 Devices Inc.净利率更高（24.0% vs 17.0%，领先7.1%）。908 Devices Inc.同比增速更快（21.2% vs 7.0%）。安捷伦科技自由现金流更多（$175.0M vs $1.3M）。过去两年908 Devices Inc.的营收复合增速更高（53.0% vs 6.9%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
908 Devices Inc.是一家专注于研发、生产高性能便携式质谱分析设备及相关解决方案的科技企业，产品覆盖生命科学研究、生物制药制造、公共安全、法医鉴定、工业过程监测等领域，服务全球科研机构、制药企业及政府部门客户。
A vs MASS — 直观对比
营收规模更大
A
是对方的103.5倍
$17.4M
营收增速更快
MASS
高出14.2%
7.0%
净利率更高
MASS
高出7.1%
17.0%
自由现金流更多
A
多$173.7M
$1.3M
两年增速更快
MASS
近两年复合增速
6.9%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $17.4M |
| 净利润 | $305.0M | $4.2M |
| 毛利率 | 52.6% | 52.7% |
| 营业利润率 | 19.6% | 17.8% |
| 净利率 | 17.0% | 24.0% |
| 营收同比 | 7.0% | 21.2% |
| 净利润同比 | -4.1% | 121.5% |
| 每股收益（稀释后） | $1.07 | $0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMASS
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $17.4M | ||
| Q3 25 | $1.7B | $14.0M | ||
| Q2 25 | $1.7B | $13.0M | ||
| Q1 25 | $1.7B | $11.8M | ||
| Q4 24 | $1.7B | $14.3M | ||
| Q3 24 | $1.6B | $14.5M | ||
| Q2 24 | $1.6B | $11.5M |
净利润AMASS
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $4.2M | ||
| Q3 25 | $336.0M | $-15.0M | ||
| Q2 25 | $215.0M | $-13.3M | ||
| Q1 25 | $318.0M | $43.6M | ||
| Q4 24 | $351.0M | $-19.4M | ||
| Q3 24 | $282.0M | $-29.3M | ||
| Q2 24 | $308.0M | $-12.5M |
毛利率AMASS
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | 52.7% | ||
| Q3 25 | 51.1% | 52.5% | ||
| Q2 25 | 51.9% | 48.9% | ||
| Q1 25 | 53.5% | 47.0% | ||
| Q4 24 | 53.9% | 46.5% | ||
| Q3 24 | 54.2% | 53.6% | ||
| Q2 24 | 54.4% | 53.8% |
营业利润率AMASS
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 17.8% | ||
| Q3 25 | 20.7% | -116.6% | ||
| Q2 25 | 18.0% | -116.3% | ||
| Q1 25 | 22.4% | -93.6% | ||
| Q4 24 | 24.0% | -116.8% | ||
| Q3 24 | 21.1% | -168.7% | ||
| Q2 24 | 23.1% | -74.5% |
净利率AMASS
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 24.0% | ||
| Q3 25 | 19.3% | -107.0% | ||
| Q2 25 | 12.9% | -102.1% | ||
| Q1 25 | 18.9% | 370.2% | ||
| Q4 24 | 20.6% | -135.6% | ||
| Q3 24 | 17.9% | -201.8% | ||
| Q2 24 | 19.6% | -109.5% |
每股收益（稀释后）AMASS
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $0.09 | ||
| Q3 25 | $1.18 | $-0.41 | ||
| Q2 25 | $0.75 | $-0.37 | ||
| Q1 25 | $1.11 | $1.23 | ||
| Q4 24 | $1.23 | $-0.58 | ||
| Q3 24 | $0.97 | $-0.84 | ||
| Q2 24 | $1.05 | $-0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $113.0M |
| 总债务越低越好 | $3.0B | — |
| 股东权益账面价值 | $6.9B | $143.7M |
| 总资产 | $12.8B | $190.1M |
| 负债/权益比越低杠杆越低 | 0.44× | — |
8季度趋势，按日历期对齐
现金及短期投资AMASS
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $113.0M | ||
| Q3 25 | $1.5B | $112.1M | ||
| Q2 25 | $1.5B | $118.6M | ||
| Q1 25 | $1.5B | $124.3M | ||
| Q4 24 | $1.3B | $69.6M | ||
| Q3 24 | $1.8B | $71.7M | ||
| Q2 24 | $1.7B | $77.4M |
总债务AMASS
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
股东权益AMASS
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $143.7M | ||
| Q3 25 | $6.4B | $136.3M | ||
| Q2 25 | $6.1B | $148.8M | ||
| Q1 25 | $6.0B | $159.4M | ||
| Q4 24 | $5.9B | $114.6M | ||
| Q3 24 | $5.9B | $131.0M | ||
| Q2 24 | $6.2B | $156.4M |
总资产AMASS
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $190.1M | ||
| Q3 25 | $12.2B | $190.9M | ||
| Q2 25 | $12.2B | $191.7M | ||
| Q1 25 | $11.9B | $196.0M | ||
| Q4 24 | $11.8B | $159.5M | ||
| Q3 24 | $11.0B | $178.3M | ||
| Q2 24 | $10.9B | $208.8M |
负债/权益比AMASS
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | $1.3M |
| 自由现金流经营现金流 - 资本支出 | $175.0M | $1.3M |
| 自由现金流率自由现金流/营收 | 9.7% | 7.6% |
| 资本支出强度资本支出/营收 | 5.2% | 0.0% |
| 现金转化率经营现金流/净利润 | 0.88× | 0.32× |
| 过去12个月自由现金流最近4个季度 | $993.0M | $-24.7M |
8季度趋势，按日历期对齐
经营现金流AMASS
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $1.3M | ||
| Q3 25 | $362.0M | $-4.2M | ||
| Q2 25 | $221.0M | $-5.8M | ||
| Q1 25 | $431.0M | $-15.0M | ||
| Q4 24 | $481.0M | $-2.2M | ||
| Q3 24 | $452.0M | $-5.6M | ||
| Q2 24 | $333.0M | $-13.0M |
自由现金流AMASS
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $1.3M | ||
| Q3 25 | $259.0M | $-4.9M | ||
| Q2 25 | $107.0M | $-5.9M | ||
| Q1 25 | $334.0M | $-15.2M | ||
| Q4 24 | $388.0M | $-2.4M | ||
| Q3 24 | $360.0M | $-5.8M | ||
| Q2 24 | $230.0M | $-13.7M |
自由现金流率AMASS
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 7.6% | ||
| Q3 25 | 14.9% | -34.9% | ||
| Q2 25 | 6.4% | -45.3% | ||
| Q1 25 | 19.9% | -128.9% | ||
| Q4 24 | 22.8% | -17.0% | ||
| Q3 24 | 22.8% | -39.7% | ||
| Q2 24 | 14.6% | -119.4% |
资本支出强度AMASS
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 0.0% | ||
| Q3 25 | 5.9% | 4.9% | ||
| Q2 25 | 6.8% | 0.9% | ||
| Q1 25 | 5.8% | 1.4% | ||
| Q4 24 | 5.5% | 1.3% | ||
| Q3 24 | 5.8% | 1.1% | ||
| Q2 24 | 6.5% | 5.6% |
现金转化率AMASS
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 0.32× | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.36× | -0.34× | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.08× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
MASS
| Products | $14.3M | 82% |
| Services | $3.0M | 18% |
